GLAND PHARMA Share price

The Company was incorporated as ‘Gland Pharma Private Limited’ a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. Subsequently the name of the Company was changed to ‘Gland Pharma Limited’ pursuant to a special resolution passed by the shareholders of the Company on December 5 1994 and a fresh certificate of incorporation dated April 25 1995 was issued by the Registrar of Companies Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act 1956.Major events and milestones of the Company :2019- Filed Dexrazoxane for Injection the first filing with the National Medical Products Administration China and received clinical waiver2018- Received ANDA approval for Enoxaparin Sodium Injection USP for the US market- Received ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% the first Ophthalmic product approval2017- Fosun Singapore acquired 74% stake in the Company2016- Obtained USFDA approval for the facilities at Jawaharlal Nehru Pharma City Visakhapatnam- Obtained USFDA approval for the manufacturing facility at Pashamylaram- Obtained USFDA approval for the facility at the Visakhapatnam Special Economic Zone2014- Obtained USFDA approval for small volume parenteral manufacturing facility at Visakhapatnam- Commissioned the Pashamylaram Unit-II manufacturing facility- Received the ‘Certificate of GMP Compliance of a Manufacturer’ from MHRA (UK) for manufacturing facility at Dundigal- Capital infusion of US$ 100 million into the Company pursuant to private equity investment aggregating to approximately US$ 200 million with KKR Floorline Investment Pte Ltd2012- Received the ‘Certificate of GMP Compliance of a Manufacturer’ from BGV Hamburg (Germany) for the manufacturing facility at Dundigal2010- Launched Heparin Sodium Injection in the US2007- Capital infusion of approximately Rs.1000 million into the Company pursuant to private equity investment aggregating to approximately Rs.1200 million with EILSF Co-Invest I LLC2004 - 2005- Launch of Enoxaparin Sodium Injection (Cutenox) in India and Rest of the world markets2003- Received USFDA approval for the manufacturing facility at Dundigal2000- Set up the in-house R&D facility at Dundigal Hyderabad1978- Incorporation of the Company by P.V.N. RajuAwards accreditations and recognitions received by the Company :2019- The Company was awarded the “Best Exporter” by the Hyderabad Customs- The Company was awarded the “Express Pharma Excellence Awards 2019” under the turnover base Rs. 500 – 2000 crore category organized by the Express Pharma and Optel Group- The Company was awarded the “Telangana Best Employer Brand Award” at the 14th Employer Branding Awards organised by the Employer Branding Institute India2018- The Company was awarded the “Top Exporter” by the Hyderabad Customs Customs and Central Excise Government of India- The Company was awarded the “Outstanding Export Performance Award” under Formulations Silver Star category by Pharmaceuticals Export Promotion Council of India2017- The Company was awarded the “Excellence in Export Performance” at the Federation of Telangana and Andhra Pradesh Chambers of Commerce and Industry instituted by Surana Group of Industries Secunderabad- The Company was awarded the “Outstanding Export Performance Award” under Formulations Fast Growing -1 category by Pharmaceuticals Export Promotion Council of India2016- The Company was awarded the “Top Exporter/Importer” by the Hyderabad Customs Commissionerate Customs and Central Excise Government of India2014- The Company was awarded the “Outstanding Exports Performance Award” under the Regional (America and Oceania) category by Pharmaceuticals Export Promotion Council of India- The Company received the BS OHSAS 18001:2007 certifying the occupational health and safety management system of the manufacturing facility at Dundigal- The Company received ISO 14001:2015 certifying the environmental management system of the manufacturing facility at Dundigal- The Company received ISO 9001:2015 certifying the quality management system of manufacturing facility at Dundigal